Cargando…

The Role of Cardiovascular and Metabolic Comorbidities in the Link between Atrial Fibrillation and Cognitive Impairment: An Appraisal of Current Scientific Evidence

Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice with implications on long-term outcomes. Metabolic disorders including diabetes mellitus and obesity are independent predictors of atrial fibrillation and present therapeutic targets to reduce both the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlTurki, Ahmed, Maj, Jakub B., Marafi, Mariam, Donato, Filippo, Vescovo, Giovanni, Russo, Vincenzo, Proietti, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956022/ https://www.ncbi.nlm.nih.gov/pubmed/31801224 http://dx.doi.org/10.3390/medicina55120767

Ejemplares similares

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
por: AlTurki, Ahmed, et al.
Publicado: (2019)

Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials
por: AlTurki, Ahmed, et al.
Publicado: (2019)

Stroke, Dementia, and Atrial Fibrillation: From Pathophysiologic Association to Pharmacological Implications
por: Russo, Vincenzo, et al.
Publicado: (2020)

Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta‐analysis
por: AlTurki, Ahmed, et al.
Publicado: (2018)

Soluble ST2 in Paroxysmal Atrial Fibrillation: a New Biomarker that Predicts Recurrence?
por: AlTurki, Ahmed
Publicado: (2018)

The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population
por: RUSSO, VINCENZO, et al.
Publicado: (2014)

COVID-19 Pandemic and Possible Rebound Phenomenon in Incidence of Acute Myocardial Infarction
por: Čulić, Viktor, et al.
Publicado: (2021)

Letter to the Editor Regarding: Acute Coronary Syndrome in the COVID-19 Pandemic: Reduced Cases and Increased Ischaemic Time by Sutherland et al. Heart Lung Circ. 2022;31(1):69-76
por: Čulić, Viktor, et al.
Publicado: (2022)

The coronavirus disease-19 pandemic and acute coronary syndrome: a specific impact in the elderly
por: Čulić, Viktor, et al.
Publicado: (2022)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
por: Trigo, Paula, et al.
Publicado: (2012)

Cryoablation in persistent atrial fibrillation – a critical appraisal
por: Tzeis, S., et al.
Publicado: (2016)

Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
por: Bahbahani, Hamad, et al.
Publicado: (2018)

Gastrointestinal comorbidities associated with atrial fibrillation
por: Laliberté, François, et al.
Publicado: (2014)

Frailty and comorbidity burden in Atrial Fibrillation
por: Salis, Francesco, et al.
Publicado: (2023)

Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials
por: Proietti, Riccardo, et al.
Publicado: (2015)

At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation
por: Leo, Donato Giuseppe, et al.
Publicado: (2023)

Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2021)

Management of antithrombotic therapy during cardiac implantable device surgery
por: AlTurki, Ahmed, et al.
Publicado: (2016)

Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up
por: RUSSO, VINCENZO, et al.
Publicado: (2013)

Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation
por: Russo, Vincenzo, et al.
Publicado: (2020)

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
por: Lane, Deirdre A, et al.
Publicado: (2020)

Publisher’s note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2022)

The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation
por: Naser, Nabil, et al.
Publicado: (2017)

Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
por: Bang, Oh Young, et al.
Publicado: (2022)

Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation
por: Witassek, Fabienne, et al.
Publicado: (2019)

Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance
por: Vio, Riccardo, et al.
Publicado: (2021)

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
por: Violi, Francesco, et al.
Publicado: (2016)

Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry
por: Gumprecht, Jakub, et al.
Publicado: (2020)

Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal
por: Schellinger, Peter D., et al.
Publicado: (2018)

Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study
por: Russo, Vincenzo, et al.
Publicado: (2019)

The association between relevant comorbidities and dementia in patients with atrial fibrillation
por: Wändell, Per, et al.
Publicado: (2018)

Headache and Psychological Comorbidities: An Appraisal of the Evidence
por: Abu-Arafeh, Ishaq
Publicado: (2023)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
por: Fan, Yongqiang, et al.
Publicado: (2022)

Postoperative atrial fibrillation and atrial epicardial fat: Is there a link?
por: van der Heijden, Claudia A.J., et al.
Publicado: (2022)

Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal
por: Galli, Mattia, et al.
Publicado: (2020)

Stroke prevention in patients with atrial fibrillation and comorbidities: evidence and common sense
por: de Groot, J. R.
Publicado: (2020)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

The “Obesity Paradox” in Patients With HFpEF With or Without Comorbid Atrial Fibrillation
por: Guo, Linjuan, et al.
Publicado: (2022)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Preexisting atrial fibrillation and myocardial infarction: only 10% of infarcts directly linked to atrial fibrillation
por: Putot, Alain, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rhmd58nm86la1074vqchvjhigr